As ROCK2 and ezrin are compartmentalized in cells and accessibility of the celastrol to its target and dephosphorylation of pre-phosphorylated ezrin could be the time-limited factor, we then treated the hepatocellular carcinoma cells with 500 nM celastrol in time gradient. This evidence concerns the gene ROCK2 and hepatocellular carcinoma.